Hostname: page-component-586b7cd67f-2brh9 Total loading time: 0 Render date: 2024-11-26T04:00:53.650Z Has data issue: false hasContentIssue false
  • English
  • Français

Tricyclic antidepressants and tryptophan in unipolar depression

Published online by Cambridge University Press:  09 July 2009

David M. Shaw ,
David A. Macsweeney ,
Robyn Hewland  and
Anthony L. Johnson
David M. Shaw
Affiliation:
Medical Research Council Neuropsychiatry Unit, West Park Hospital, Epsom, Surrey
David A. Macsweeney
Affiliation:
Medical Research Council Neuropsychiatry Unit, West Park Hospital, Epsom, Surrey
Robyn Hewland
Affiliation:
Medical Research Council Neuropsychiatry Unit, West Park Hospital, Epsom, Surrey
Anthony L. Johnson
Affiliation:
Medical Research Council Neuropsychiatry Unit, West Park Hospital, Epsom, Surrey
Get access Rights & Permissions [Opens in a new window]

Synopsis

Depressed patients (unipolar) were given one of the following combinations in an attempt to test aspects of the ‘amine hypothesis’ and to find a preferential therapy: (1) clomipramine; (2) clomipramine and tryptophan; (3) desipramine and clomipramine, and (4) desipramine and tryptophan. Treatment (2) should have given optimal potentiation of 5-HT neurones and (3) and (4) should have acted similarly on both serotoninergic and adrenergic pathways. In no group was there any evidence of accelerated recovery, indicating that the process of conversion to normal mood may be more complex than suggested by most versions of the amine hypothesis.

Type
Original Article
Information
Psychological Medicine , Volume 5 , Issue 3 , August 1975 , pp. 276 - 278
Copyright
Copyright © Cambridge University Press 1975

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Beck, A. T. (1967). Depression. Harper and Row: New York.Google Scholar
Carlsson, A., Corrodi, H., Fuxe, K., and Hökfelt, T. (1969a). Effects of antidepressant drugs on the depletion of intraneuronal brain 5-hydroxytryptamine stores caused by 4-methyl-α-ethyl-meta-tyramine. European Journal of Pharmacology, 5, 357–366.CrossRefGoogle ScholarPubMed
Carlsson, A., Corrodi, H., Fuxe, K., and Hökflet, T. (1969b). Effects of some antidepressant drugs on the depletion of intraneuronal brain catecholamine stores caused by 4,α-dimethyl-meta-tyramine. European Journal of Pharmacology, 5, 367–373.CrossRefGoogle ScholarPubMed
Goodwin, F. K., Post, R. M., and Kotin, J. (1972). Cocaine: clinical effects in depressed patients. (Abstract.) Psycho-pharmacologia, 26, suppl., 82.Google Scholar
Gram, L. F., Overø, K. F., Anderson, J., and Kirk, L. (1972). Lu 5–003 i antidepressiv terapi. En kontrolleret klinisk gennemprøvning med samtidig måling af farmakokinetiske parametre. Nordisk Psykiatrisk Tidskrift, 26, 361.CrossRefGoogle Scholar
Grizzle, J. E., and Allen, D. M. (1969). Analysis of growth and dose response curves. Biometrics, 25, 357–381.CrossRefGoogle ScholarPubMed
Pichot, P., Piret, J., and Clyde, D. J. (1966). Analyse de la symptomatologie dépressive subjective. Revue de Psychologic Appliquée, 16, 101–115.Google Scholar
Shaw, D. M., Johnson, A. L., and MacSweeney, D. A. (1972). Tricyclic antidepressants and tryptophan in unipolar affective disorder. Lancet, 2, 1245.CrossRefGoogle ScholarPubMed